GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Quick Ratio

FibroBiologics (STU:SG0) Quick Ratio : 1.23 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. FibroBiologics's quick ratio for the quarter that ended in Sep. 2024 was 1.23.

FibroBiologics has a quick ratio of 1.23. It generally indicates good short-term financial strength.

The historical rank and industry rank for FibroBiologics's Quick Ratio or its related term are showing as below:

STU:SG0' s Quick Ratio Range Over the Past 10 Years
Min: 0.27   Med: 0.82   Max: 12.48
Current: 1.23

During the past 3 years, FibroBiologics's highest Quick Ratio was 12.48. The lowest was 0.27. And the median was 0.82.

STU:SG0's Quick Ratio is ranked worse than
75.12% of 1503 companies
in the Biotechnology industry
Industry Median: 3.41 vs STU:SG0: 1.23

FibroBiologics Quick Ratio Historical Data

The historical data trend for FibroBiologics's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Quick Ratio Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Quick Ratio
0.27 0.37 1.00

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 8.31 1.00 0.64 0.64 1.23

Competitive Comparison of FibroBiologics's Quick Ratio

For the Biotechnology subindustry, FibroBiologics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Quick Ratio distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Quick Ratio falls into.



FibroBiologics Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

FibroBiologics's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(8.45-0)/8.421
=1.00

FibroBiologics's Quick Ratio for the quarter that ended in Sep. 2024 is calculated as

Quick Ratio (Q: Sep. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(7.386-0)/6.016
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FibroBiologics  (STU:SG0) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


FibroBiologics Quick Ratio Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

FibroBiologics Headlines

No Headlines